Advertisement

Opioids in Gastroparesis: Is There a Better Way?

  • Richard WroblewskiEmail author
  • Jennifer Repanshek
Chapter

Abstract

Acute exacerbations of gastroparesis may cause significant pain, nausea, and vomiting. Standard modalities such as opioids have a negative effect on gastric motility. Opioids also come with the risk of dependence, and there is a movement to find better and safer alternatives for acute pain management. Antipsychotic medications reduce opioid use and provide symptomatic relief for patients suffering acute exacerbations of gastroparesis.

Keywords

Gastroparesis Acute pain management Ketamine Antipsychotics 

References

  1. 1.
    Bharucha AE. Epidemiology and natural history of gastroparesis. Gastroenterol Clin N Am. 2015;44:9–19.  https://doi.org/10.1016/j.gtc.2014.11.002.CrossRefGoogle Scholar
  2. 2.
    Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2012;108:18–37.  https://doi.org/10.1038/ajg.2012.373.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Bielefeldt K. Factors influencing admission and outcomes in gastroparesis. Neurogastroenterol Motil. 2013;25:389–98, e294.  https://doi.org/10.1111/nmo.12079.CrossRefPubMedGoogle Scholar
  4. 4.
    American Academy of Emergency Medicine. Model emergency department pain treatment guidelines [internet]. 2013 [updated 10 Mar 2013; cited 23 Mar 2018]; Available from http://www.aaem.org/publications/news-releases/model-emergency-department-pain-treatment-guidelines
  5. 5.
    Glare P, Miller J, Nikolova T, Tickoo R. Treating nausea and vomiting in palliative care: a review. Clin Interv Aging. 2011;6:243–59.  https://doi.org/10.2147/CIA.S13109.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kim S, Shin I, Kim J, Kang H, Mun J, Yang S, Yoon J. Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment. Psychosomatics. 2006;47:440–2.  https://doi.org/10.1176/appi.psy.47.5.440.CrossRefPubMedGoogle Scholar
  7. 7.
    Ramirez R, Stalcup P, Croft B, Darracq MA. Haloperidol undermining gastroparesis symptoms (HUGS) in the emergency department. Am J Emerg Med. 2017;35:1118–20.  https://doi.org/10.1016/j.ajem.2017.03.015.CrossRefPubMedGoogle Scholar
  8. 8.
    Roldan C, Chambers K, Paniagua L, Patel S, Cardenas-Turanzas M, Chathampally Y. Randomized controlled double-blind trial comparing haloperidol combined with conventional therapy to conventional therapy alone in patients with symptomatic gastroparesis. Acad Emerg Med. 2017;24:1307–14.  https://doi.org/10.1111/acem.13245.CrossRefPubMedGoogle Scholar
  9. 9.
    Phillips WJ, Tollefson B, Johnson A, Abell T, Lerant A. Relief of acute pain in chronic idiopathic gastroparesis with intravenous phentolamine. Ann Pharmacother. 2006;40:2032–6.  https://doi.org/10.1345/aph.1h255.CrossRefPubMedGoogle Scholar
  10. 10.
    Pourmand A, Mazer-Amirshahi M, Royall C, Alhawas R, Shesser R. Low dose ketamine use in the emergency department, a new direction in pain management. Am J Emerg Med. 2017;35:918–21.  https://doi.org/10.1016/j.ajem.2017.03.005.CrossRefPubMedGoogle Scholar
  11. 11.
    Ahern TL, Herring AA, Anderson ES, Madia VA, Fahimi J, Frazee BW. The first 500: initial experience with widespread use of low-dose ketamine for acute pain management in the ED. Am J Emerg Med. 2015;33:197–201.  https://doi.org/10.1016/j.ajem.2014.11.010.CrossRefPubMedGoogle Scholar
  12. 12.
    Ahern TL, Herring AA, Miller S, Frazee BW. Low-dose ketamine infusion for emergency department patients with severe pain. Pain Med. 2015;16:1402–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Temple University HospitalPhiladelphiaUSA

Personalised recommendations